Week 4 Flashcards
1
Q
Fentanyl: trade name
A
Duragesic
2
Q
Fentanyl: indications
A
- intrapartum pain management
- opioid analgesics
- used as an adjunct to epidural analgesia
3
Q
Fentanyl: dosage
A
- 50-100 mcg
- may be repeated every hour
- may be given by PCA
4
Q
Fentanyl: ADRs
A
- pruritis
- n/v
- delayed respiratory depression: for up to 12 hr after administration
5
Q
Fentanyl: nursing implications
A
- record baseline maternal V/S and FHR
- nurse should observe for signs of subarachnoid puncture or intravascular injection
- assess maternal BP and FHR every 5 min furing first 15 min after administration
- repeat at 30 min and at 1 hour after procedure
- assess bladder every 2 hour
- may need to obtain order for catheter placement
- observe neonate for respiratory depression (esp if drug given w/in 4 hours of birth)
- can use adjunctive therapy for nausea (promethazine)
- have naloxone and respiratory resuscitation equipment ready
6
Q
Bupivicaine: trade name
A
Marcaine
7
Q
Bupivicaine: indications
A
- epidural block
- for intrapartum pain management
- local anesthetic: for episiotomy, to repair tear or laceration
8
Q
Bupivicaine: dosage
A
- 10-20 mL
- administer in increments of 3-5 mL
- do a test dose of 3 mL before full administration
9
Q
Bupivicaine: ADRs
A
- maternal hypoTN
- bladder distention
- prolonged 2nd stage of labor
- epidural catheter migration
- cesarean births
- maternal fever
- can cause seizure if injected into vessel
10
Q
Bupivicaine: nursing implications
A
- often times administered with epi to prevent bleeding
- record baseline maternal V/S and FHR
- nurse should observe for signs of subarachnoid puncture or intravascular injection
- assess maternal BP and FHR every 5 min furing first 15 min after administration
- repeat at 30 min and at 1 hour after procedure
- assess bladder every 2 hour and encourage mom to void
- may need to obtain order for catheter placement
- prehydrate woman with LR or NS
- displace uterus with wedge under woman’s side to enhance placental perfusion
- assess FHR for signs of impaired placental perfusion
- if impaired placental perfusion or hypoTN occur: administer nonadditive IV fluid, reposition woman on side, administer 8-10 L/min of O2
11
Q
what is the trade name for terbutaline sulfate?
A
Brethine
12
Q
Terbutaline sulfate: indications
A
- tocolytic: management of preterm labor–>inhibition of uterine contractions
13
Q
Terbutaline sulfate: dosage
A
- IV: 0.01-0.05 mg/min
- inc rate by 0.01 mg/min at 10-30 min intervals until contractions or maximum dose of 0.08 mg/min is reached
- maintain dose for 1 hour, then reduce rate at 30 min intervals to reach minimum maintenance dose when contractions stop
- continue maintenance dose for 12 horus
- subQ: intermittent injections of 0.25 mg every 4 hour
14
Q
Terbutaline sulfate: ADRs
A
- CV: maternal and fetal tachycardia, palpitations, cardiac dysrhythmias, chest pain, wide pulse pressure
- resp: dyspnea, chest discomfort
- CNS: tremors, restlessness, weakness, HA, dizziness
- metabolic: hypokalemia, hyperglycemia
- GI: n/v, reduced bowel motility
- skin: flushing, diaphoresis
15
Q
Terbutaline sulfate: nursing implications
A
- do not use for longer than 48-72 hour
- assess woman’s apical HR and lung sounds before administering each dose
- drug toxicity and d/c drug if: maternal HR over 120 bpm or respiratory findings such as “wet” lung sounds or more rapid rate
- report all non-reassuring maternal and fetal assessments to physician
- have propranolol ready as a reversal agent
16
Q
what is the trade name for nifedipine?
A
Procardia
17
Q
Nifedipine: indications
A
- CCB used for tocolysis
- reduce uterine contractions b/c Ca is essential for muscular contractions (for preterm labor)
18
Q
Nifedipine: dosage
A
- oral loading dose: 10-20 mg
- continued oral therapy: 10-20 mg every 3-6 hr until contractions are rare
- followed by long acting formulations of 30-60 mg every 8-12 hr until antepartum steroids have been administered
19
Q
Nifedipine: ADRs
A
- flushing
- HA
- inc in maternal and fetal HR
- maternal postural hypotension
- hyperglycemia
20
Q
Nifedipine: nursing implications
A
- observe for SEs
- report maternal pulse greater than 120 bpm
- educate on possible dizziness or faintness
- sit or stand slowly and call for assistance if needed
21
Q
what is the trade name for betamethasone?
A
Celestone
22
Q
Betamethasone: indications
A
- acceleration of fetal lung maturity to reduce the incidence and severity of respiratory distress syndrome (RDS)
- greatest benefits if at least 24 hrs elapse b/w initial dose and birth of preterm infant
- indicated if gestation b/w 24-34 wks
23
Q
Betamethasone: dosage
A
- 12 mg IM for 2 doses, 24 hours apart
24
Q
Betamethasone: ADRs
A
- few b/c short term use of drug
- pulmonary edema possible secondary to sodium and fluid retention
- fever and elevated pulse rate secondary to infection
- UTI
- hyperglycemia
25
Betamethasone: nursing considerations
* educate woman on potential benefits, but tell her drug cannot prevent all complications of prematurity
* if woman has diabetes, more frequent blood glucose checks are needed
* WBCs greater than 20,000 may indicate infection
* assess lung sounds
* report chest pain, heaviness, or dyspnea
* report pain or burning with urination
* assess V/S for fever and elevated pulse
26
what is the trade name for Indomethacin?
Indocin
27
Indomethacin: indications
* tocolytic: to inhibit uterine contractions (for preterm labor)
* can be used to normalize volume of amniotic fluid if hydramnios is present
28
Indomethacin: dosage
* loading dose: 50 mg orally
29
Indomethacin: ADRs
* Maternal:
* GI: n/v/heartburn
* asthm ain aspirin sensitive women
* inc BP in hypertensive women
* Fetal:
* constriction of ductus arteriosus
* pulmonary HTN
* oligohydramnios (usually returns to normal when drug is d/c)
30
Indomethacin: nursing implications
* limit use to preterm labor before 32 weeks gestation
* use for no longer than 48-72 consecutive hours
* observe for GI SEs
* observe for abnormal bleeding (such as prolonged bleeding after injection and bruising with no apparent cause)
* watch for signs of infection, b/c drug may mask them
* check height of fundus at beginning of therapy and daily thereafter to identify reduced amniotic fluid
* observe for decreased fetal movements and absent FHR accelerations w/ fetal movement (may indicate fetal condition deteriorating)
* use U/S and fetal echocardiography to determine if drug having adverse effects on fetus